Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.83 - $10.12 $83,689 - $145,272
-14,355 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$5.86 - $9.85 $416 - $699
71 Added 0.5%
14,355 $92,000
Q3 2021

Nov 16, 2021

BUY
$8.38 - $26.13 $24,058 - $75,019
2,871 Added 25.16%
14,284 $174,000
Q2 2021

Aug 16, 2021

BUY
$7.33 - $15.2 $83,657 - $173,477
11,413 New
11,413 $102,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0

About IMPEL PHARMACEUTICALS INC


  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.